NYSE · Healthcare
Onterris, Inc. (ONT)
As-reported financials and recent SEC filings for Onterris, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$830.5M
Net income
$-843,000
Net margin
-0.1%
Diluted EPS
$-0.14
ROE
-0.2%
P/E (TTM)
133.6×
Market cap
$724.2M
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $830.5M | $696.4M | $624.2M | $544.4M | $546.4M |
| Gross profit | $334.3M | $278.2M | $240.3M | $192.5M | $177.4M |
| Operating income | $11.7M | $-36.7M | $-28.4M | $-28.0M | $-9.5M |
| Net income | $-843,000 | $-62.3M | $-30.9M | $-31.8M | $-25.3M |
| Diluted EPS | $-0.14 | $-2.22 | $-1.57 | $-1.62 | $-1.56 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-08
View on EDGAR →42026-06-05
View on EDGAR →42026-05-12
View on EDGAR →42026-05-12
View on EDGAR →SCHEDULE 13G2026-05-11
View on EDGAR →8-K2026-05-11
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-06
View on EDGAR →Go deeper on ONT
Search Onterris, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.